These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29673854)

  • 1. Silencing of Non-POU-domain-containing octamer-binding protein stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice via NF-κB signaling pathway.
    Zhang K; Zhang F; Yang JM; Kong J; Meng X; Zhang M; Zhang C; Zhang Y
    Int J Cardiol; 2018 Jul; 263():96-103. PubMed ID: 29673854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of NONO inhibits abdominal aortic aneurysm in apolipoprotein E-knockout mice via collagen deposition and inflammatory inhibition.
    Xu X; Zhang F; Lu Y; Yu S; Sun W; Sun S; Cheng J; Ma J; Zhang M; Zhang C; Zhang Y; Zhang K
    J Cell Mol Med; 2019 Nov; 23(11):7449-7461. PubMed ID: 31512366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
    Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
    J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice.
    Li B; Zhao Y; Liu H; Meng B; Wang J; Qi T; Zhang H; Li T; Zhao P; Sun H; Xu J; Song H; Dong Z; An F
    PLoS One; 2016; 11(2):e0148273. PubMed ID: 26848572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40.
    Wang B; Qian H; Yang H; Xu L; Xu W; Yan J
    Int J Cardiol; 2013 Feb; 163(1):34-9. PubMed ID: 21640399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE
    Wang XL; Sun W; Zhou YL; Li L
    Int J Biochem Cell Biol; 2018 Dec; 105():70-77. PubMed ID: 30336263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.
    Zhao D; Tong L; Zhang L; Li H; Wan Y; Zhang T
    Mol Med Rep; 2016 Dec; 14(6):4983-4990. PubMed ID: 27840935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 inhibition suppresses inflammatory response and reduces carotid atherosclerotic plaque formation in ApoE mice.
    Mu H; Wang L; Zhao L
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28009484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane prevents vulnerable plaque disruption in apolipoprotein E-knockout mice by increasing collagen deposition and inhibiting inflammation.
    Hou Y; Lin X; Lei Z; Zhao M; Li S; Zhang M; Zhang C; Yu J; Meng T
    Br J Anaesth; 2020 Dec; 125(6):1034-1044. PubMed ID: 32943192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.
    Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J
    J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
    Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
    Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
    Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
    Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Prolyl-4-Hydroxylase-
    Cao XQ; Liu XX; Li MM; Zhang Y; Chen L; Wang L; Di MX; Zhang M
    Dis Markers; 2016; 2016():1701637. PubMed ID: 27818566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
    Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
    Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPKα inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2α/miRNA-124 axis.
    Liang WJ; Zhou SN; Shan MR; Wang XQ; Zhang M; Chen Y; Zhang Y; Wang SX; Guo T
    J Mol Med (Berl); 2018 May; 96(5):403-412. PubMed ID: 29502204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 inhibition reduces low shear stress-induced plaque formation.
    Qin WD; Zhang F; Qin XJ; Wang J; Meng X; Wang H; Guo HP; Wu QZ; Wu DW; Zhang MX
    Int J Biochem Cell Biol; 2016 Mar; 72():63-72. PubMed ID: 26783939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathway.
    Zhang K; Huang XZ; Li XN; Feng M; Li L; Cai XJ; Zhang C; Liu XL; Zhang MX; Zhang Y; Wang XL; Zhang M
    Arch Biochem Biophys; 2012 Dec; 528(2):127-33. PubMed ID: 23022409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.